JANE STREET GROUP, LLC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 3 filers reported holding APREA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$16,864
-68.8%
50,950
-29.2%
0.00%
Q2 2022$54,000
-11.5%
71,959
+239.4%
0.00%
Q4 2021$61,000
-76.6%
21,202
-58.5%
0.00%
Q3 2021$261,000
+350.0%
51,059
+330.7%
0.00%
Q4 2020$58,00011,8560.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders